Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined vs IV Tranexamic Acid in Joint Replacement
NCT05874583Completed
- Sponsor
- Mongi Slim University Hospital
- Start
- Dec 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tranexamic acid (2 arms), sponsored by Mongi Slim University Hospital. Primary endpoint: Haemoglobin decline at 24 hours. Started Dec 2021; status: completed.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT05874583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05874583.